Achten A, van Empel VPM, Weerts J, Mourmans S, Beckers-Wesche F, Spanjers M, Gingele A, Brunner-La Rocca HP, -van Sanders S, Knackstedt C (2024) Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years. Heart Vessels 39(10):857–866

Article  PubMed  PubMed Central  Google Scholar 

Azuma M, Kato S, Sawamura S, Fukui K, Takizawa R, Nakayama N, Ito M, Hibi K, Utsunomiya D (2025) Prevalence of cardiac amyloidosis in atrial fibrillation: a CMR study prior to catheter ablation. Heart Vessels 40(2):131–139

Article  PubMed  Google Scholar 

González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585–2594

Article  PubMed  Google Scholar 

Henein MY, Pilebro B, Lindqvist P (2022) Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy. Heart Vessels 37(9):1562–1569

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art review. J Am Coll Cardiol 73(22):2872–2891

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS (2016) Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 1(8):880–889

Article  PubMed  Google Scholar 

Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, Perotte A, Maurer MS (2021) Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: A test in evolution. JACC Cardiovasc Imaging 14(6):1221–1231

Article  PubMed  Google Scholar 

Asif T, Gomez J, Singh V, Doukky R, Nedeltcheva A, Malhotra S (2021) Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: perils and pitfalls. J Nucl Cardiol 28(1):104–111

Article  PubMed  Google Scholar 

Kottam A, Hanneman K, Schenone A, Daubert MA, Sidhu GD, Gropler RJ, Garcia MJ (2023) State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association. Circ Cardiovasc Imaging 16(11):e000081

Article  PubMed  Google Scholar 

Li W, Uppal D, Wang YA-O, Xu X, Kokkinidis DG, Travin MI, Tauras JM (2021) Nuclear imaging for the diagnosis of cardiac amyloidosis in 2021. Dianostics(Basel) 11(6):996

CAS  Google Scholar 

Suomalainen O, Ahokas T, Hippeläinen E, Heliö T, Uusitalo V (2025) Validation of [(99m)Tc]Tc-HMDP SPECT/CT myocardium-to-blood ratio for the detection of ATTR cardiomyopathy. J Nucl Cardiol 47:102199

Article  PubMed  Google Scholar 

Verfaillie GA-O, Franck CA-O, De Crop A, Beels LA-O, D’Asseler YA-O, Bacher KA-O (2023) A systematic review and meta-analysis on the radiation dose of computed tomography in hybrid nuclear medicine imaging. EJNMMI Phys 10(1):32

Article  PubMed  PubMed Central  Google Scholar 

Manrique A, Dudoignon D, Brun S, N’Ganoa C, Cassol E, Legallois D, Lavie-Badie Y, Agostini D, Lairez O (2019) Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. EJNMMI Res 9(1):117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart (2021) A diagnosis and treatment of cardiac amyloidosis. A position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur J Heart Fail 23(4):512–526

Article  PubMed  Google Scholar 

Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39(30):2799–2806

Article  CAS  PubMed  Google Scholar